Update on WHO Ethics and AI Activities
Stay informed about the latest developments in the WHO Ethics and AI initiatives. This update covers outcomes from recent online meetings, steps towards future collaboration, governance principles, ethical challenges, and ongoing contributions to regulatory considerations. Explore forthcoming activities of the ethics sub-group and how to participate in shaping the future of AI ethics in health care.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
FGAI4H-M-042-A01 E-meeting, 28-30 September 2021 Source: Chair WG-Ethics Title: WG-Ethics updates - Att.1: WG-Ethics & WHO experts Ethics on AI updates Discussion Purpose: Andreas REIS, WHO E-mail: reisa@who.int Contact: Rohit MALPANI, WHO E-mail: malpanir@who.int Contact: Abstract: This PPT contains an update on the WG-Ethics & WHO experts Ethics on AI activities. Outcome from the recent meeting online, 22 Sep. 2021 are highlighted, identifying steps towards future collaboration.
Ethics & Governance of Artificial Intelligence (AI) for Health: WHO Guidance
WHO Guidance document Opportunities and ethical challenges Consensus principles Governance Recommendations Checklists for MoH, designers, providers 12/06/2025 | Expert Group on Ethics & Governance of AI in Health 3
On-going collaboration with WHO FG AI4H Contribution to overview of regulatory considerations on AI for health Ethics definitions for Glossary of key AI terms Drafting of ethical considerations for clinical evaluation guidance. 4
Forthcoming activities of ethics sub-group Participation of ethics subject-matter experts within Trial Audit teams. Develop and periodically update Q&A that includes both general ethics questions as well as ethics-related issues and challenges arising from each Topic Group. 5
Forthcoming activities of ethics sub-group Open to additional suggestions of functions and outputs of ethics- subgroup. Any ideas or suggestions? Email: reisa@who.int 6
